WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006091885) A REGISTRY METHOD AND CONTROL SYSTEM FOR DEA SCHEDULE II-V MEDICINES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/091885    International Application No.:    PCT/US2006/006730
Publication Date: 31.08.2006 International Filing Date: 23.02.2006
IPC:
C07D 323/00 (2006.01), A61K 31/519 (2006.01), C07D 475/06 (2006.01)
Applicants: DR PHARMA NOVA, LLC [US/US]; One Northgate Square, Greenburg, PA 15601 (US) (For All Designated States Except US).
REIS, Alan, J. [US/US]; (US) (For US Only).
SCHAFMEISTER, Christian [US/US]; (US) (For US Only)
Inventors: REIS, Alan, J.; (US).
SCHAFMEISTER, Christian; (US)
Agent: LUDWIG, Peter, S.; Darby & Darby P.C., 7 World Trade Center, 250 Greenwich Street, New York, NY 10007-0042 (US)
Priority Data:
60/656,232 24.02.2005 US
Title (EN) A REGISTRY METHOD AND CONTROL SYSTEM FOR DEA SCHEDULE II-V MEDICINES
(FR) PROCEDE D'ENREGISTREMENT ET SYSTEME DE CONTROLE POUR MEDICAMENTS DES LISTES II-V DE LA DRUG ENFORCEMENT AGENCY (DEA)
Abstract: front page image
(EN)The present invention provides compositions and methods for synthesizing labeled drugs. The present invention further provides methods for preventing or stopping prescription drug abuse for all agents registered as a Drug Enforcement Agency (DEA) schedule II through schedule V medications. According to the present invention, methods are provided for monitoring patient compliance with prescribed drug treatment. The present invention also provides methods for facilitating a replacement prescription when a patient is left without access to their prescribed drug. Furthermore, the present invention provides a method to improve employee compliance with an employer's drug policies via either a voluntary or compulsory system for enhanced drug testing.
(FR)Compositions et procédés permettant de synthétiser des médicaments marqués, et procédés de prévention ou d'arrêt d'abus de médicaments prescrits sur ordonnance pour tous les produits enregistrés comme médicaments des listes II à V de la DEA. On décrit des procédés de vérification de l'adaptation entre un patient et un traitement par médicament prescrit, et des procédés permettant de faciliter l'accès à un médicament prescrit en remplacement lorsqu'un patient ne peut pas accéder au médicament qui lui a été prescrit, et enfin un procédé permettant d'améliorer l'adaptation entre un employé et telle ou telle politique de l'employeur liée à l'utilisation des médicaments, à travers un système volontaire ou obligatoire d'essai renforcé de médicament.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)